An Independent US FDA: Gottlieb Supports Position, But Is Pessimistic About Prospects

In an interview with the Pink Sheet, Scott Gottlieb agrees with other ex-commissioners that there are benefits to an independent agency, but he thinks political forces would prevent it from ever happening.

FDASignBldg21Entrance_1200x675

Scott Gottlieb officially joined the chorus of former commissioners calling for the US Food and Drug Administration to be an independent agency, although he is pessimistic that it would ever become a reality.

In an interview with the Pink Sheet and sister publication Medtech Insight, Gottlieb contended there would be benefits to having...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Agency Leadership

More from Pink Sheet